原癌基因Pokemon及核转录因子E2F3在喉鳞癌中的表达及其临床意义
The Expression of Pokemon and E2F3 in Laryngeal Squamous Cell Carcinoma and Their Clinical Significance
刘丽英;王琳;闫完平;周合心;
1:临汾职业技术学院附属医院耳鼻咽喉科
2:临汾市人民医院耳鼻咽喉科
3:临汾市第四人民医院耳鼻咽喉科
4:临汾市第二人民医院五官科
摘要关键词基金项目(Foundation):作者参考文献1季文樾,杜强,关超,等.1115例喉癌患者的生存分析[J].中华耳鼻咽喉科杂志,2004,39:17.
2 Maeda T,Hobbs RM,Merghoub T,et al.Role of the proto-oncogene Pokemon in cellular transformation and ARF re-pression[J].Nature,2005,433:278.
3 Leone G,DeGregori J,Yan Z,et al.E2F3activity is regula-ted during the cell cycle and is required for the induction of S phase[J].Genes Dev,1998,12:2 120.
4 Zindy F,Williams RT,Baudino TA,et al.Arf tumor sup-pressor promoter monitors latent oncogenic signals in vivo[J].Proc Natl Acad Sci U S A,2003,100:15 930.
5 Birner P,Schindl M,Obermair A,et al.Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J].Cancer Res,2000,60:4 693.
6 Morrison DJ,Pendergrast PS,Stavropoulos P,et al.FBI-1,a factor that binds to the HIV-1inducer of short transcripts(IST),is a POZ domain protein[J].Nucleic Acids Res,1999,27:1 251.
7 Lee DK,Suh D,Edenberg HJ,et al.POZ domain transcrip-tion factor,FBI-1,represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA bind-ing activity of Sp1[J].J Biol Chem,2002,277:26 761.
8 Koken MH,Reid A,Quignon F,et al.Leukemia-associated retinoic acid receptor alpha fusion partners,PML and PLZF,heterodimerize and colocalize to nuclear bodies[J].Proc Natl Acad Sci U S A,1997,94:10 255.
9 Chen WY,Zeng X,Carter MG,et al.Heterozygous disrup-tion of Hic1predisposes mice to a gender-dependent spectrumof malignant tumors[J].Nat Genet,2003,33:197.
10 Kong LJ,Chang JT,Bild AH,et al.Compensation and spe-cificity of function within the E2Ffamily[J].Oncogene,2007,26:321.
11 Kort EJ,Farber L,Tretiakova M,et al.The E2F3-On-comir-1axis is activated in Wilms'tumor[J].Cancer Res,2008,68:4 034.
12 Cunningham JM,Vierkant RA,Sellers TA,et al.Cell cycle genes and ovarian cancer susceptibility:a tagSNP analysis[J].Br J Cancer,2009,101:1 461.
13胡力仁,吴长利,胡海龙,等.E2F3和AR在前列腺癌组织中的表达及意义[J].天津医药,2012,40:1.
14 Clark PA,Llanos S,Peters G.Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2[J].On-cogene,2002,21:4 498.
15赵凌冰,古丽那尔.阿布拉江,李晓梅,等.在口腔鳞状细胞癌中Pokemon、Ku70的表达及临床病理学意义的研究[J].口腔医学研究,2011,27:994.
16 Zhao ZH,Wang SF,Yu L,et al.Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance[J].Chin Med J(Engl),2008,121:445.
17高伟,隋军,李晓江,等.Pokemon在鼻咽癌中的表达及临床意义[J].现代肿瘤医学,2009,17:37.
18 Ziebold U,Lee EY,Bronson RT,et al.E2F3loss has oppo-sing effects on different pRB-deficient tumors,resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas[J].Mol Cell Biol,2003,23:6 542.
19 Schumacher U,Adam E,Feldhaus S,et al.Cell differentia-tion and chemotherapy influence p53and Mdm2immunoreac-tivity in human HT29colon cancer cells grown in scid mice[J].Cancer Lett,2001,166:215.
20 Ginsberg D.E2F3-a novel repressor of the ARF/p53path-way[J].Dev Cell,2004,6:742.
21赵智宏,王胜发,丛德刚,等.非小细胞肺癌中pokemon表达与p 14ARF、bcl-2的相关性及对预后的影响[J].肿瘤,2008,28:121.